Next generation antibody drug market to reach $33.53 billion by 2030 at 15.4% cagr, driven by increasing focus on personalized medicine.
Read More
Nexletol market to reach $6.07 billion by 2030 at 13.5% cagr, driven by increasing cases of cardiovascular diseases.
Read More
Neutropenia biologic drug treatment market to reach $20.88 billion by 2030 at 7.2% cagr, driven by rise in number of cancer cases globally.
Read More
Neutralizing antibody market to reach $447.16 billion by 2030 at 11.6% cagr, driven by rising prevalence of infectious diseases.
Read More
Neurotoxin-inspired peptide market to reach $2.31 billion by 2030 at 13.5% cagr, driven by rising prevalence of neurological disorders.
Read More
Neurotoxin market to reach $12.43 billion by 2030 at 9.1% cagr, driven by surge in cosmetic procedures to improve appearance.
Read More
Neuroregeneration therapy market to reach $20.5 billion by 2030 at 12.6% cagr, driven by rising prevalence of neurological disorders and aging population.
Read More
Neuromuscular blocking drug market to reach $5.23 billion by 2030 at 5.0% cagr, driven by increasing number of surgical procedures.
Read More
The global microcarrier market to reach $4.15 billion by 2030 at 12.0% CAGR, driven by increasing prevalence of cancer cases.
Read More
Neurological Disorder Drugs Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
Neurological disorder drugs market to reach $116.27 billion by 2030 at 5.3% cagr, driven by increasing prevalence of neurological diseases.
Read More